Diabetes Care, Vol 18, Issue 3 393-397, Copyright © 1995 by American Diabetes Association

ARTICLES

Treatment of hypercholesterolemia in NIDDM with policosanol

O Torres, AJ Agramonte, J Illnait, R Mas Ferreiro, L Fernandez and JC Fernandez
Julio Trigo Hospital, Havana, Cuba.

OBJECTIVE--To determine whether elevated levels of cholesterol and low-density lipoprotein (LDL) cholesterol in non-insulin-dependent diabetes mellitus (NIDDM) patients could be decreased by policosanol, a new cholesterol-lowering drug. NIDDM predisposes patients to coronary artery disease (CAD) through the direct action of hyperglycemia on the arteries as well as the dyslipidemia induced by NIDDM. RESEARCH DESIGN AND METHODS--This double-blind placebo-controlled trial was performed in 29 patients with NIDDM and hypercholesterolemia. After stable glycemic control was achieved by diet and/or oral hypoglycemic drugs, patients were instructed to follow a cholesterol-lowering diet for 6 weeks. Patients who met entry criteria received, under double-blind conditions, policosanol (5 mg) or placebo tablets twice a day for 12 weeks. RESULTS--Policosanol (10 mg/day) significantly reduced total cholesterol by 17.5% and LDL cholesterol by 21.8% compared with baseline and placebo. Furthermore, high-density lipoprotein (HDL) cholesterol was raised by 11.3% (not significant), and triglycerides showed a statistically nonsignificant decrease of 6.6%. These changes in lipid profile were similar to those induced by policosanol in nondiabetic patients with type II hyperlipoproteinemia. CONCLUSIONS--Glycemic control was unaffected by treatment. No clinically or biochemically adverse effects attributable to treatment were observed. Only one patient (placebo) withdrew from the trial because of an adverse experience (erythema). We concluded that policosanol is effective and safe in patients with NIDDM and hypercholesterolemia.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Illnait, G. Castano, E. Alvarez, L. Fernandez, R. Mas, S. Mendoza, and R. Gamez Effects of Policosanol (10 mg/d) Versus Aspirin (100 mg/d) in Patients With Intermittent Claudication: A 10-Week, Randomized, Comparative Study Angiology, July 1, 2008; 59(3): 269 - 277. [Abstract] [PDF]

				M. F Dulin, L. F Hatcher, H. C Sasser, and T. A Barringer Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1543 - 1548. [Abstract] [Full Text] [PDF]

				G. Castano, R. Mas, R. Gamez, L. Fernandez, and J. Illnait Effects of Policosanol and Ticlopidine in Patients with Intermittent Claudication: A Double-Blinded Pilot Comparative Study Angiology, July 1, 2004; 55(4): 361 - 371. [Abstract] [PDF]

				J. L. Hargrove, P. Greenspan, and D. K. Hartle Nutritional Significance and Metabolism of Very Long Chain Fatty Alcohols and Acids from Dietary Waxes Experimental Biology and Medicine, March 1, 2004; 229(3): 215 - 226. [Abstract] [Full Text] [PDF]

				G. Castano, R. Mas, L. Fernandez, R. Gamez, and J. Illnait Effects of Policosanol and Lovastatin in Patients with Intermittent Claudication: A Double-Blind Comparative Pilot Study Angiology, January 1, 2003; 54(1): 25 - 38. [Abstract] [PDF]

				G. Castaño, R. Más, J.C. Fernández, J. Illnait, L. Fernández, and E. Alvarez Effects of Policosanol in Older Patients With Type II Hypercholesterolemia and High Coronary Risk J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2001; 56(3): 186M - 193. [Abstract] [Full Text]

				G. Castano, R. M. Ferreiro, L. Fernandez, R. Gamez, J. Illnait, and J. C. Fernandez A Long-Term Study of Policosanol in the Treatment of Intermittent Claudication Angiology, February 1, 2001; 52(2): 115 - 125. [Abstract] [PDF]

				G. Castano, R. Mas, J. Roca, L. Fernandez, J. Illnait, J. C. Fernandez, E. Selman, and R. Mas A Double-Blind, Placebo-Controlled Study of the Effects of Policosanol in Patients with Intermittent Claudication Angiology, February 1, 1999; 50(2): 123 - 130. [Abstract] [PDF]